Search research articles
Contact Us
Filters
Showing results (1461-1470 of 1,938) with videos related to
Page
of 194
Sort By:
Nature
|
September 25, 2009
Direct RNA sequencing
Fatih Ozsolak, Adam R Platt, Dan R Jones, et al.
Neoplasia (New York, N.Y.)
|
October 28, 2008
p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors
Stuart J Gallagher, John F Thompson, James Indsto, et al.
ANZ Journal of Surgery
|
November 1, 2019
Current management of patients with melanoma who are found to be sentinel node-positive
Amanda A G Nijhuis, Andrew J Spillane, Jonathan R Stretch, et al.
American Journal of Human Genetics
|
January 1, 1995
Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome
B C Broughton, A F Thompson, S A Harcourt, et al.
Pigment Cell & Melanoma Research
|
April 6, 2013
Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression
Georgina V Long, James S Wilmott, Lauren E Haydu, et al.
Lancet (London, England)
|
May 30, 2001
Single nucleotide polymorphism in prohibitin 3' untranslated region and breast-cancer susceptibility
E R Jupe, A A Badgett, B R Neas, et al.
Annals of Surgery
|
October 7, 2011
Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma
Rajmohan Murali, Lauren E Haydu, Michael J Quinn, et al.
Journal of the American Academy of Dermatology
|
April 25, 2009
Sentinel node biopsy and standard of care for melanoma
Charles M Balch, Donald L Morton, Jeffrey E Gershenwald, et al.
Journal of the American Medical Directors Association
|
August 25, 2025
Social Connectedness and Successful Nursing Home Discharge After Heart Failure Hospitalization
Andrew L Chen, Blythe G Chen, Lan Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2012
Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma
Alexander M Menzies, Lauren E Haydu, Lydia Visintin, et al.
Page
of 194
Search research articles
Search
Showing results (1461-1470 of 1,938) with videos related to
Sort By:
Page
of 194
Nature
|
September 25, 2009
Direct RNA sequencing
Fatih Ozsolak, Adam R Platt, Dan R Jones, et al.
Neoplasia (New York, N.Y.)
|
October 28, 2008
p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors
Stuart J Gallagher, John F Thompson, James Indsto, et al.
ANZ Journal of Surgery
|
November 1, 2019
Current management of patients with melanoma who are found to be sentinel node-positive
Amanda A G Nijhuis, Andrew J Spillane, Jonathan R Stretch, et al.
American Journal of Human Genetics
|
January 1, 1995
Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome
B C Broughton, A F Thompson, S A Harcourt, et al.
Pigment Cell & Melanoma Research
|
April 6, 2013
Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression
Georgina V Long, James S Wilmott, Lauren E Haydu, et al.
Lancet (London, England)
|
May 30, 2001
Single nucleotide polymorphism in prohibitin 3' untranslated region and breast-cancer susceptibility
E R Jupe, A A Badgett, B R Neas, et al.
Annals of Surgery
|
October 7, 2011
Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma
Rajmohan Murali, Lauren E Haydu, Michael J Quinn, et al.
Journal of the American Academy of Dermatology
|
April 25, 2009
Sentinel node biopsy and standard of care for melanoma
Charles M Balch, Donald L Morton, Jeffrey E Gershenwald, et al.
Journal of the American Medical Directors Association
|
August 25, 2025
Social Connectedness and Successful Nursing Home Discharge After Heart Failure Hospitalization
Andrew L Chen, Blythe G Chen, Lan Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2012
Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma
Alexander M Menzies, Lauren E Haydu, Lydia Visintin, et al.
Page
of 194